tiprankstipranks
Advertisement
Advertisement

JP:4886 Stock Latest News

ASKA Pharmaceutical’s Q1 Profit Slumps, Full‑Year Outlook Steady
Company AnnouncementsASKA Pharmaceutical’s Q1 Profit Slumps, Full‑Year Outlook Steady
4d ago
4886
ASKA Pharmaceutical Posts Weaker Q1 Earnings but Holds Dividend and Full-Year Guidance
PremiumCompany Announcements
ASKA Pharmaceutical Posts Weaker Q1 Earnings but Holds Dividend and Full-Year Guidance
4d ago
4886
ASKA Pharma to Grant Restricted Treasury Shares via Employee Share Plan
PremiumCompany Announcements
ASKA Pharma to Grant Restricted Treasury Shares via Employee Share Plan
26d ago
4886
ASKA Pharma Uses Treasury Shares to Expand Performance-Linked Restricted Stock Plan
PremiumCompany Announcements
ASKA Pharma Uses Treasury Shares to Expand Performance-Linked Restricted Stock Plan
26d ago
4886
ASKA Pharma Wins Broad Shareholder Backing, Adopts Anti-Takeover Safeguard
PremiumCompany Announcements
ASKA Pharma Wins Broad Shareholder Backing, Adopts Anti-Takeover Safeguard
1M ago
4886
ASKA Pharma revamps restricted share pay as it shifts to new governance structure
PremiumCompany AnnouncementsASKA Pharma revamps restricted share pay as it shifts to new governance structure
3M ago
4886
ASKA Pharmaceutical switches auditors to EY ShinNihon to support global expansion
Premium
Company Announcements
ASKA Pharmaceutical switches auditors to EY ShinNihon to support global expansion
3M ago
4886
ASKA Seeks Shareholder Mandate for Defense Against Potential Dalton-Led Takeover Move
Premium
Company Announcements
ASKA Seeks Shareholder Mandate for Defense Against Potential Dalton-Led Takeover Move
3M ago
4886
ASKA Pharma to Embed Corporate Philosophy and Shift to Audit Committee Governance
PremiumCompany Announcements
ASKA Pharma to Embed Corporate Philosophy and Shift to Audit Committee Governance
3M ago
4886
ASKA Pharma Corrects Pension Accounting Data Without Affecting FY2026 Earnings
PremiumCompany Announcements
ASKA Pharma Corrects Pension Accounting Data Without Affecting FY2026 Earnings
3M ago
4886
ASKA Pharmaceutical Overhauls Board, Taps Industry Veteran for Governance Role
PremiumCompany Announcements
ASKA Pharmaceutical Overhauls Board, Taps Industry Veteran for Governance Role
3M ago
4886
ASKA Pharmaceutical Delivers Record FY2025 Results on Overseas Expansion and Margin Gains
PremiumCompany Announcements
ASKA Pharmaceutical Delivers Record FY2025 Results on Overseas Expansion and Margin Gains
3M ago
4886
ASKA Pharmaceutical Boosts Dividend as Profits Rise but Signals Margin Pressure Ahead
PremiumCompany AnnouncementsASKA Pharmaceutical Boosts Dividend as Profits Rise but Signals Margin Pressure Ahead
3M ago
4886
ASKA Pharmaceutical Lifts Dividend and Adopts Progressive Payout Policy
Premium
Company Announcements
ASKA Pharmaceutical Lifts Dividend and Adopts Progressive Payout Policy
3M ago
4886
ASKA Pharmaceutical Board Rejects Activist Shareholder’s Director Proposal
Premium
Company Announcements
ASKA Pharmaceutical Board Rejects Activist Shareholder’s Director Proposal
3M ago
4886
ASKA sets 2035 long-term vision and unveils 2028 medium-term growth plan
PremiumCompany Announcements
ASKA sets 2035 long-term vision and unveils 2028 medium-term growth plan
5M ago
4886
ASKA Pharma Launches Restricted Stock Plan for Employee Shareholders
PremiumCompany Announcements
ASKA Pharma Launches Restricted Stock Plan for Employee Shareholders
5M ago
4886
ASKA Pharmaceutical to Adopt Audit Committee Structure and Streamline Governance
PremiumCompany Announcements
ASKA Pharmaceutical to Adopt Audit Committee Structure and Streamline Governance
5M ago
4886
ASKA Pharma Hits Record Sales but Profit Slips on Higher R&D and Overseas Costs
PremiumCompany Announcements
ASKA Pharma Hits Record Sales but Profit Slips on Higher R&D and Overseas Costs
6M ago
4886
ASKA Pharmaceutical Boosts Sales but Sees Profit Decline, Keeps FY2025 Outlook Intact
PremiumCompany AnnouncementsASKA Pharmaceutical Boosts Sales but Sees Profit Decline, Keeps FY2025 Outlook Intact
6M ago
4886
ASKA Pharmaceutical Revises FY2025 Financial Forecasts Amid Strategic Adjustments
Premium
Company Announcements
ASKA Pharmaceutical Revises FY2025 Financial Forecasts Amid Strategic Adjustments
9M ago
4886
ASKA Pharmaceutical Reports Q2 FY2025 Financial Results with Revised Full-Year Forecast
Premium
Company Announcements
ASKA Pharmaceutical Reports Q2 FY2025 Financial Results with Revised Full-Year Forecast
9M ago
4886

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >